Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says

Nov. 18 (Bloomberg) -- U.S. regulators revoked approval of Roche AG’s Avastin as a treatment for metastatic breast cancer, a move the drugmaker has said could put as much as 800 million Swiss francs ($873 million) in revenue at risk. Avastin, with $6.2 billion in 2010 sales, didn’t extend ...

Related News:-

• Panel Votes to Revoke Avastin Breast-Cancer Approval - WSJ.com


An advisory committee of the FDA voted 6-0 that accelerated approval of the drug Avastin as a breast-cancer treatment should be revoked, handing a defeat to Avastin ...

• FDA Panel Says Revoke Approval of Avastin (bevacizumab) for Breast ...


An advisory committee of the Food and Drug Administration (FDA) voted 12-1 to recommend revoking approval of the drug Avastin as a treatment for breast cancer, saying the drug ...

• FDA: Government Should Revoke Avastin's Approval for Breast Cancer


A panel of cancer experts has ruled for a second time that Avastin, the best-selling cancer drug in the world, should no longer be used in breast cancer patients ...

• Roche’s Avastin Faces FDA Withdrawal in Breast Cancer


Roche Holding AG’s top-selling drug Avastin should no longer be used to treat breast cancer after recent studies failed to show a benefit, U.S. regulators said ...

• FDA Panel Says Avastin's Breast Cancer Indication Should Be Removed


An FDA advisory panel called on the agency to revoke its approval of Roche's Avastin as a breast-cancer treatment after studies failed to show benefit.

• Genentech Prepares to Vouch for Avastin’s Use in Breast Cancer ...


A slice of Genentech’s $7.7 billion Avastin franchise is at stake as the company tomorrow tries to persuade the FDA to reinstate Avastin’s metastatic breast cancer (MBC ...

• FDA Moves To Pull Approval Of Avastin For Breast Cancer


The Food and Drug Administration says data from recent clinical studies show the benefits of the drug Avastin for breast cancer patients don't outweigh the risks.

• WGVU: FDA panel rejects Avastin for breast cancer use (2011-06-29 ...


A worker makes its way on a bridge at Swiss pharmaceutical company Roche plant in Basel

• US FDA panel rejects Avastin for breast cancer use - Caring4Cancer


Comprehensive cancer Information ... By Anna Yukhananov. SILVER SPRING, Md. (Reuters) - U.S. health advisers delivered a blow to Roche Holding on Wednesday, voting to reject ...